2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$63.97+$0.11 (+0.17%)
Price as of Oct 23, 2026 7:54 PM EDT- $28.3BMarket Cap
- 74.71%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$63.97+$0.11 (+0.17%)
Earnings Score
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -0.84% | ||
12-Month Momentum | 61.25% | ||
3-Month Risk Adjusted Momentum | -8.32% | ||
12-Month Risk Adjusted Momentum | 273.04% |
True Yield
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 1.47% | ||
Net Buyback Yield | 1.29% | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |